A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice

被引:418
作者
Boisvert, WA
Santiago, R
Curtiss, LK
Terkeltaub, RA
机构
[1] VA Med Ctr, San Diego, CA 92161 USA
[2] Scripps Res Inst, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA
关键词
atherogenesis; inflammation; bone marrow transplantation; chemokines; GRO alpha;
D O I
10.1172/JCI1195
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic macrophage-mediated inflammation is central to atherosclerosis. A role of the monocyte chemotactic and activating C-C chemokine JE/monocyte chemotactic protein-1 has been proposed. However, the human C-X-C chemokines growth-regulated oncogene (GRO alpha) and IL-8, and their shared receptor, CXCR-2, also can be expressed at sites of chronic inflammation. Because we detected CXCR-2 in the intima of human atherosclerotic lesions, we examined the role of leukocyte CXCR-2 expression in affecting lesion cellularity. Atherosclerosis-susceptible LDL receptor-deficient mice were irradiated, successfully repopulated with bone marrow cells that either lacked or expressed mIL-8RH (the homologue of CXCR-2), and fed an atherogenic diet for 16 wk. In recipients of mIL-8RH+/+ marrow, mIL-8RH colocalized with densely accumulated intimal MOMA-2 positive macrophages. In contrast, lesions in recipients of mIL-8RH-/- marrow lacked mIL-8RH, had little intimal MOMA-2 staining, and were less extensive. The mIL-8RH ligand KC/GRO alpha was detected in the intima of all aortic atherosclerotic lesions. Thus, the capacity of leukocytes to express mIL-8RH, and associated intralesional expression of its ligands such as KC/GRO alpha, mediated the intimal accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.
引用
收藏
页码:353 / 363
页数:11
相关论文
共 67 条
[1]   The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor [J].
Ahuja, SK ;
Murphy, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20545-20550
[2]   CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B - Determinants of high affinity binding and receptor activitation are distinct [J].
Ahuja, SK ;
Lee, JC ;
Murphy, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :225-232
[3]  
ANISOWICZ A, 1991, J IMMUNOL, V147, P520
[4]   Interleukin-8 production by macrophages from atheromatous plaques [J].
Apostolopoulos, J ;
Davenport, P ;
Tipping, PG .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) :1007-1012
[5]   The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells [J].
Babi, LFS ;
Moser, B ;
Soler, MTP ;
Moser, R ;
Loetscher, P ;
Villiger, B ;
Blaser, K ;
Hauser, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) :2056-2061
[6]   Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice [J].
Boisvert, WA ;
Spangenberg, J ;
Curtiss, LK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) :340-347
[7]   TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN APOLIPOPROTEIN E-DEFICIENT MICE BY BONE-MARROW TRANSPLANTATION [J].
BOISVERT, WA ;
SPANGENBERG, J ;
CURTISS, LK .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1118-1124
[8]  
BOZIC CR, 1994, J BIOL CHEM, V269, P29355
[9]  
BROWN KA, 1990, 2 INT S CHEM CYT LON
[10]   Involvement of interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: Evidence from mice lacking the murine IL-8 receptor homologue [J].
Broxmeyer, HE ;
Cooper, S ;
Cacalano, G ;
Hague, NL ;
Bailish, E ;
Moore, MW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1825-1832